Progression of comorbidities in youth with overweight or obesity during the COVID-19 pandemic

BMC Pediatr. 2023 Sep 19;23(1):471. doi: 10.1186/s12887-023-04259-9.

Abstract

Background: Childhood obesity rates have continued to increase with the COVID-19 pandemic. However, data are limited on the impact of increasing obesity on associated comorbidities.

Methods: We evaluated the progression of overweight- or obesity-associated comorbidities by investigating change in laboratory results pre-COVID-19 pandemic and post-COVID-19 pandemic onset in youth with overweight or obesity. We defined progression of comorbidities based on increase in category rather than absolute change in value.

Results: HbA1c progression was seen in 19%, and LDL cholesterol progression was seen in 26%, as defined by categories. HbA1c progression and LDL cholesterol progression were significantly correlated. HbA1c and LDL cholesterol progression were significantly associated with older age and Hispanics, respectively.

Conclusion: The results indicate youths with overweight or obesity have experienced progression of comorbidities during the COVID-19 pandemic. This study emphasizes the importance of early detection of comorbidities among a high-risk pediatric population.

Keywords: COVID-19 pandemic; Comorbidities; Obesity; Prediabetes; Youth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • COVID-19* / epidemiology
  • Child
  • Cholesterol, LDL
  • Glycated Hemoglobin
  • Humans
  • Overweight / epidemiology
  • Pandemics
  • Pediatric Obesity* / epidemiology

Substances

  • Cholesterol, LDL
  • Glycated Hemoglobin